Format

Send to

Choose Destination
Adv Clin Exp Med. 2017 Jul;26(4):717-722. doi: 10.17219/acem/62325.

The role of CD36 receptor in the pathogenesis of atherosclerosis.

Author information

1
1st Department of General and Endocrine Surgery, Medical University of Bialystok, Poland.
2
SKN Dental Biochemistry at the Department of Conservative Dentistry, Medical University of Bialystok, Poland.
3
Department of Physiology, Medical University of Bialystok, Poland.

Abstract

Atherosclerosis is a progressive, chronic inflammation in artery walls. Oxidized low density lipoproteins (ox-LDL) play an important role in atherosclerotic plaque formation. ox-LDL are taken up by macrophages mainly through scavenger receptors, among which CD36 is considered to be the most important. Animal studies have shown that crossing atherogenic mice with a strain lacking the expression of CD36 prevented the development of atherosclerosis despite a diet rich in saturated LCFA. In humans, autopsy studies performed in obese patients have demonstrated increased expression of CD36 receptor on macrophages, comprised within atherosclerotic plaques. Until recently it had been believed that CD36 is a major player in atherosclerosis progression in humans. However, recent studies challenge this conviction, showing increased incidence of coronary heart disease in the subgroup of patients with decreased expression of CD36. This article reviews the role of CD36 receptor in the development of atherosclerosis. The authors also discuss current possibilities to interfere with CD36, their potential benefits and hazards.

KEYWORDS:

CD36 receptor; atherosclerosis; ox-LDL

PMID:
28691408
DOI:
10.17219/acem/62325
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wroclaw Medical University
Loading ...
Support Center